Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Michael C Kaufmann"'
Autor:
Ping Chi, Yu Chen, Cristina R. Antonescu, Peter Besmer, Ingo K. Mellinghoff, William D. Tap, Takahiro Taguchi, John Wongvipat, Ferdinando Rossi, Sinan Zhu, Dong Gao, Michael C. Kaufmann, Yuanyuan Xie, Shipra Shukla, Yuedan Chen, Devan Murphy, Zhen Cao, Inna Sirota, Leili Ran
Supplementary Figure Legends
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::934e571f3403486d58a25476cdd48323
https://doi.org/10.1158/2159-8290.22530681
https://doi.org/10.1158/2159-8290.22530681
Autor:
Ping Chi, Yu Chen, Cristina R. Antonescu, Peter Besmer, Ingo K. Mellinghoff, William D. Tap, Takahiro Taguchi, John Wongvipat, Ferdinando Rossi, Sinan Zhu, Dong Gao, Michael C. Kaufmann, Yuanyuan Xie, Shipra Shukla, Yuedan Chen, Devan Murphy, Zhen Cao, Inna Sirota, Leili Ran
Supplementary Figure 1: Etv1 is required for intramuscular and myenteric ICC development. Supplementary Figure 2: Etv1 ablation with tamoxifen decreases Etv1 and Kit expression in Kit^delta558/+;Etv1^flox/flox;Rosa26^CreERT2/CreERT2 mice. Supplementa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::75960034644fb3105568d252a04acf5a
https://doi.org/10.1158/2159-8290.22530678.v1
https://doi.org/10.1158/2159-8290.22530678.v1
Autor:
Ping Chi, Yu Chen, Cristina R. Antonescu, Peter Besmer, Ingo K. Mellinghoff, William D. Tap, Takahiro Taguchi, John Wongvipat, Ferdinando Rossi, Sinan Zhu, Dong Gao, Michael C. Kaufmann, Yuanyuan Xie, Shipra Shukla, Yuedan Chen, Devan Murphy, Zhen Cao, Inna Sirota, Leili Ran
Supplementary Table 2: Gene sets enriched among genes DOWNregulated by tamoxifen treatment (Etv1 ablation) in murine GIST-like tumors.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d8968ed33ef79387f851bfa7c8d70c33
https://doi.org/10.1158/2159-8290.22530672.v1
https://doi.org/10.1158/2159-8290.22530672.v1
Autor:
Ping Chi, Yu Chen, Cristina R. Antonescu, Peter Besmer, Ingo K. Mellinghoff, William D. Tap, Takahiro Taguchi, John Wongvipat, Ferdinando Rossi, Sinan Zhu, Dong Gao, Michael C. Kaufmann, Yuanyuan Xie, Shipra Shukla, Yuedan Chen, Devan Murphy, Zhen Cao, Inna Sirota, Leili Ran
Supplementary Table 3: Gene sets enriched among genes UPregulated by tamoxifen treatment (Etv1 ablation) in murine GIST-like tumors.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::162037e87ec89d4c80f0fa5c356b770b
https://doi.org/10.1158/2159-8290.22530669
https://doi.org/10.1158/2159-8290.22530669
Autor:
Ping Chi, Yu Chen, Cristina R. Antonescu, Peter Besmer, Ingo K. Mellinghoff, William D. Tap, Takahiro Taguchi, John Wongvipat, Ferdinando Rossi, Sinan Zhu, Dong Gao, Michael C. Kaufmann, Yuanyuan Xie, Shipra Shukla, Yuedan Chen, Devan Murphy, Zhen Cao, Inna Sirota, Leili Ran
Supplementary Table 1: Differentially expressed genes (p1.5) between oil and tamoxifen treated tumors to conditionally ablate Etv1.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b7628407a193331f0abac555cf64f444
https://doi.org/10.1158/2159-8290.22530675.v1
https://doi.org/10.1158/2159-8290.22530675.v1
Publikováno v:
The Lancet Infectious Diseases
The Lancet. Infectious Diseases
The Lancet. Infectious Diseases
WHO has listed several priority diseases with epidemic potential for which there are no, or insufficient, medical countermeasures. In response, the Bill & Melinda Gates Foundation (with support from PricewaterhouseCoopers) coordinated subject matter
Autor:
Inna Sirota, Yuanyuan Xie, Dong Gao, Sinan Zhu, Yuedan Chen, Ping Chi, Leili Ran, Yu Chen, Zhen Cao, John Wongvipat, Shipra Shukla, Michael C. Kaufmann, Ingo K. Mellinghoff, Takahiro Taguchi, Ferdinando Rossi, Peter Besmer, Cristina R. Antonescu, William D. Tap, Devan Murphy
Publikováno v:
Cancer discovery. 5(3)
Gastrointestinal stromal tumor (GIST), originating from the interstitial cells of Cajal (ICC), is characterized by frequent activating mutations of the KIT receptor tyrosine kinase. Despite the clinical success of imatinib, which targets KIT, most pa